How much does ruxolitinib tablets/ruxolitinib cost per month?

Ruxolitinib is a drug that targets diseases such as myelofibrosis, polycythemia vera, and graft-versus-host disease. Its brand name is Jakafi, etc. It is an oral tablet that usually needs to be taken twice a day. The dosage of ruxolitinib tablets will be adjusted according to the patient's condition and the doctor's prescription.

Generally speaking, the dose of ruxolitinib tablets needs to be adjusted according to factors such as the patient's weight, disease type, severity of illness, etc. For the treatment of myelofibrosis and polycythemia vera, doctors usually start using low-dose ruxolitinib tablets in the first four weeks of treatment, and then gradually increase the dose, but no more than once every 2 weeks. For the treatment of graft-versus-host disease, doctors may start with a low dose of ruxolitinib tablets and gradually increase the dose after at least 3 days of treatment. In the treatment of acute or chronic GVHD, your doctor may gradually reduce the dose of ruxolitinib after at least 6 months of treatment.

The common specifications of ruxolitinib phosphate tablets currently on the domestic market include20mg*14 tablets and 5mg*60 tablets. Taking the specification of 5mg*60 tablets per box as an example, a patient may use about one box per month. However, because each patient takes a different dose, the length of time a box of ruxolitinib tablets can be used will vary from person to person. The market price of the drug sold in China is around 3,000 yuan per box, and this drug has also been included in medical insurance. Cheaper generic drugs are also sold overseas, and their drug ingredients are basically the same as those of the original research. For example, the price of produced by Bangladesh Pharmaceutical Factory5mg*50 tablets is about more than 1,000 yuan (the price may fluctuate due to the exchange rate).